Your session is about to expire
← Back to Search
Delta-9-Tetrahydrocannabinol's (Delta-9-THC) effects on pain for Fibromyalgia
Study Summary
This trial looks at whether THC, CBD, or a placebo can help with chronic non-cancer pain.
- Fibromyalgia
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Which members of the population are qualified to participate in this investigation?
"Eligibility for this trial necessitates that applicants suffer from chronic pain, be of adult age (18-50), and uniformly experience symptoms. Altogether, 75 participants are sought after."
How many participants can potentially join this clinical trial?
"Indeed, as evidenced by the information on clinicaltrials.gov, this medical study is currently in pursuit of participants. It was initially published on February 1st 2018 and has undergone its most recent update on March 8th 2022. Furthermore, it requires 75 patients to be recruited from a single site."
Are there any other reports that examine the potential of CBD to help with pain symptoms?
"Currently, 104 medical studies are being conducted to analyze the effects of Cannabidiol (CBD) on pain management. Nineteen trials have already entered Phase 3 and Belmont, Massachusetts is a major hub for this research with 331 worldwide locations running related tests."
Is this research currently recruiting participants?
"Evidenced by recent edits on clinicaltrials.gov, this study is actively seeking volunteers for participation. The trial was initially posted in February of 2018 and its information has been amended most recently in March of 2022."
Is there an upper limit for eligibility in this trial?
"Eligibility for this trial requires that the patient's age falls between 18 and 50 years old."
What disorders and symptoms are typically alleviated through Cannabidiol (CBD) therapy?
"CBD is typically prescribed as a supplemental treatment for those who do not respond to standard therapies. In addition, it has been used to manage symptoms associated with multiple sclerosis, pharmacotherapy and pain-related symptoms."
Share this study with friends
Copy Link
Messenger